SanBio : Notice Concerning Changes to Our Lineup of Corporate Officers

	July 1, 2021
Company name:	SanBio Co., Ltd.
Representative:	Keita Mori, Representative Director
	and President
	(TSE Mothers Code: 4592)
Contact:	Yoshihiro Kakutani, Corporate Officer
	of Management Administration
	(TEL. [phone])

Notice Concerning Changes to Our Lineup of Corporate Officers

SanBio Company Limited (hereafter, the "Company") hereby announces that its Board of Directors has decided through a meeting held on the date of this notice to implement the following changes to its lineup of corporate officers, effective on July 1, 2021.

1. Changes

With the departure of Corporate Officer Hiroshi Yamamoto, Representative Director, Executive Vice President and Chief Operating Officer (COO) Akihiro Tsujimura will assume the additional offices of Business Head (Japan/Asia) and CEO of subsidiary SanBio Asia Pte. Ltd. (based in Singapore), positions that were previously held by Yamamoto. Following his separation, Yamamoto will continue to support the Company as a senior advisor, providing assistance as it aims to receive manufacturing and marketing approval for regenerative cell medicine SB623 as a treatment for chronic effects associated with traumatic brain injury (TBI program) and establish the post-launch framework necessary to ensure the medicine's success.

SanBio Co, Ltd.

		Former position	New position
	Akihiro Tsujimura	Representative Director, Executive	Representative Director,
		Vice President and COO	Executive Vice President, COO,
			and Business Head (Japan/Asia)
	Hiroshi Yamamoto	Corporate Officer and Business
		Head (Japan/Asia)	-
SanBio, Inc.
		Former position	New position
	Akihiro Tsujimura	Director and CEO	Director and CEO (no change)

SanBio Asia Pte. Ltd.

1

	Former position	New position
Hiroshi Yamamoto	Director and CEO	-
Akihiro Tsujimura	Director	Director and CEO

2. Career summary of Mr. Akihiro Tsujimura

Name		Career summary
	1992	Joined Nichimen Corp. (current Sojitz Corp.)
	2001	President & CEO, Biaxis Packaging Sales Inc., an
		overseas joint venture of Nichimen
Akihiro Tsujimura	2004	Joined Santen Pharmaceutical Co., Ltd.
(DOB: Dec. 26, 1967)	2012	Corporate Officer, Santen Pharmaceutical/ President
		& CEO, Santen Inc.
	2015	Senior Corporate Officer and Head of Asia Business,
		Santen Pharmaceutical
	2016	Executive Corporate Officer and Head of Corporate
		Development Division, in charge of Asia and North
		America Businesses, Santen Pharmaceutical/ President
		& CEO, Santen Inc.
	2017	Director, Santen Pharmaceutical
	2018	Joined SanBio Co., Ltd.
		Senior Managing Executive Officer, SanBio/ CEO,
		SanBio, Inc.
	2019	Executive Officer and Senior Managing Director,
		SanBio/ CEO, SanBio, Inc.
	2020	Executive Vice President and COO, SanBio/ CEO,
		SanBio, Inc.
	2021	Representative Director, Executive Vice President and
		COO, SanBio/ CEO, SanBio, Inc.

2